Credits Earned (2025) Crédits obtenus

Redeem Prepaid Membership

Tools for Practice Outils pour la pratique


#102 Coughing up the Data on Croup


CLINICAL QUESTION
QUESTION CLINIQUE
Are glucocorticoids beneficial for mild to moderate croup and, if so, is lower dose equivalent to standard dose?


BOTTOM LINE
RÉSULTAT FINAL
Glucocorticoids, including dexamethasone, are beneficial in the treatment of mild to moderate croup, with a number needed to treat (NNT) of 5 for symptom improvement and a NNT of 17 for return to care. Low-dose dexamethasone (0.15 mg/kg) may be equivalent to the more commonly prescribed 0.6 mg/kg. 



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
A systematic review (38 trials, 4,299 patients) evaluating glucocorticoids (the majority used dexamethasone) for mild to moderate croup found:1 
  • Significant improvement in croup symptoms at six hours: Number Needed to Treat (NNT) 5 (95% Confidence Interval 3 to 11). 
    • Similar improvement at 12 and 24 hours. 
  • Fewer return visits to emergency and/or (re)admissions: NNT 17 (13 to 28). 
  • Shorter time spent in emergency or hospital: mean difference 12 hours (5 to 19 hours). 
  • No reported adverse events. 
The above review included two small randomized controlled trials (137 patients with mild to moderate croup) that compared 0.15 mg/kg to 0.6 mg/kg of dexamethasone. There was no difference in: 
  • Change in croup score from baseline at six hours, Standard Mean Difference -0.02 (-0.37 to 0.32). 
  • Return visits and/or (re)admissions, Risk Ratio 1.04 (0.62 to 1.75).  
Limitations: small sample size. 

CONTEXT
CONTEXTE
  • Even children with mild croup (croup score <2) benefit from glucocorticoid treatment.2 
  • Symptom improvement of steroids may be evident in ten minutes, with statistically significant improvement at 30 minutes.3 
  • A retrospective observational study found reduced hospital and intensive care admission rates, length of stay and intubations when 0.6 mg/kg dexamethasone was introduced and used in the hospital protocol (19801995).4 These rates did not change when 0.6mg/kg was replaced by 0.15 mg/kg in 1995.5  


peter entwistle October 24, 2024

god to know evidence for mild croup

Sarah Kronis May 18, 2025

Good to know


Latest Tools for Practice
Derniers outils pour la pratique

#403 A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

Does treating male sexual partners of females undergoing treatment for bacterial vaginosis infection decrease recurrence?
Read Lire 0.25 credits available Crédits disponibles

#402 Nipple Confusion or Nonsense? Pacifiers and Breastfeeding Duration

In term infants, does restricting early use of pacifiers result in higher rates of breastfeeding up to 6 months of age?
Read Lire 0.25 credits available Crédits disponibles

#401 Vape Expectations: Are electronic cigarettes the real deal for smoking cessation? (Update)

Are nicotine-containing e-cigarettes more effective than other available options for smoking cessation?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Christina Korownyk MD CCFP
  • G. Michael Allan MD CCFP
  • Michael R Kolber BSc MD CCFP MSc
  • Ricky D. Turgeon BSc(Pharm) ACPR PharmD

1. Russell KF, Liang Y, O'Gorman K, et al. Cochrane Database Syst Rev. 2011; (1):CD001955.

2. Bjornson CL, Klassen TP, Williamson J, et al. N Engl J Med. 2004; 351(13):1306–13.

3. Dobrovoljac M, Geelhoed GC. Emerg Med Australas. 2012; 24(1):79–85.

4. Geelhoed GC. Ann Emerg Med. 1996; 28:621–6.

5. Dobrovoljac M, Geelhoed GC. Emerg Med Australas. 2009; 21(4):309–14.

Authors do not have any conflicts of interest to declare.

Most recent review: 29/01/2018

By: RIcky D Turgeon BSc(Pharm) ACPR PharmD, G Michael Allan MD CCFP

Comments:

Evidence reviewed: January 29, 2018. Evidence updated: none. Bottom line: No change.

Learning at a glance
Yearly credits
Acquired ()
Your content by topic
Cardiology Dermatology Emergency
My Bookmarks